The Centers for Disease Control and Prevention today identified vitamin E acetate as a “potential chemical of concern” in biologic samples from patients with vaping-associated lung injuries. The agency tested lung fluid samples from 29 patients with the condition (called EVALI) in 10 states and found vitamin E acetate in all 29 samples. “These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lungs,” CDC said. It also found tetrahydrocannabinol (THC) in 82% of the samples and nicotine in 62% of the samples. CDC yesterday updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 2,051 in 49 states, the District of Columbia and the U.S. Virgin Islands, including 39 confirmed deaths. CDC and the Food and Drug Administration continue to investigate the cause of the illness, and encourage health care providers to report possible cases to their state or local health department.

Headline
A study conducted by the University of Utah examined variations in risk behaviors for colorectal, cervical and breast cancer and trends in screening across…
Headline
The Department of Health and Human Services Oct. 27 announced a new initiative to improve breast cancer screening and detection efforts. The initiative, led by…
Headline
The Department of Health and Human Services Oct. 20 launched a national plan focused on kidney care. HHS said the plan would address the root cause of kidney…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…
Headline
A survey released Sept. 10 by the National Comprehensive Cancer Network highlights ongoing shortages of cancer medications. All responding cancer centers…
Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…